SK150694A3 - 1-(phenylalkylaminoalkoxy)-5-phenylpyrazole compounds, as their method and intermediates for their production - Google Patents
1-(phenylalkylaminoalkoxy)-5-phenylpyrazole compounds, as their method and intermediates for their production Download PDFInfo
- Publication number
- SK150694A3 SK150694A3 SK1506-94A SK150694A SK150694A3 SK 150694 A3 SK150694 A3 SK 150694A3 SK 150694 A SK150694 A SK 150694A SK 150694 A3 SK150694 A3 SK 150694A3
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- group
- compounds
- hydrogen
- lower alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4341749A DE4341749A1 (de) | 1993-12-08 | 1993-12-08 | 3-(Phenylalkylaminoalkyloxy)-5-phenylpyrazol- Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK150694A3 true SK150694A3 (en) | 1995-07-11 |
Family
ID=6504420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1506-94A SK150694A3 (en) | 1993-12-08 | 1994-12-06 | 1-(phenylalkylaminoalkoxy)-5-phenylpyrazole compounds, as their method and intermediates for their production |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0663395B1 (fi) |
| JP (1) | JP3492433B2 (fi) |
| KR (1) | KR950017965A (fi) |
| CN (1) | CN1109051A (fi) |
| AT (1) | ATE201200T1 (fi) |
| AU (1) | AU7769494A (fi) |
| CA (1) | CA2137446A1 (fi) |
| CZ (1) | CZ303194A3 (fi) |
| DE (2) | DE4341749A1 (fi) |
| ES (1) | ES2156135T3 (fi) |
| FI (1) | FI945750A (fi) |
| HU (1) | HUT68518A (fi) |
| IL (1) | IL111539A0 (fi) |
| NO (1) | NO944722L (fi) |
| NZ (1) | NZ264883A (fi) |
| PL (1) | PL306155A1 (fi) |
| RU (1) | RU94045839A (fi) |
| SK (1) | SK150694A3 (fi) |
| ZA (1) | ZA949537B (fi) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9422708D0 (en) * | 1994-11-10 | 1995-01-04 | Zeneca Ltd | Herbicides |
| FR2773153A1 (fr) * | 1997-12-29 | 1999-07-02 | Rhone Poulenc Agrochimie | Nouveaux composes fongicides |
| EP1829873A1 (en) * | 2006-03-02 | 2007-09-05 | Laboratorios Del Dr. Esteve, S.A. | Pyrrazole derivatives as sigma receptors antagonists |
| EP1829866A1 (en) * | 2006-03-02 | 2007-09-05 | Laboratorios Del Dr. Esteve, S.A. | Sigma receptor inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1001161A (en) * | 1972-05-05 | 1976-12-07 | Burton K. Wasson | 5-(3-substituted amino-2-hydroxypropoxy)1,3-disubstituted pyrazoles and method of preparation |
| DE2828529A1 (de) * | 1978-06-29 | 1980-01-17 | Kali Chemie Pharma Gmbh | Neue 5-phenylpyrazol-derivate, verfahren zu deren herstellung und arzneimittel |
| FR2479219A1 (fr) * | 1980-04-01 | 1981-10-02 | Nativelle Sa Ets | Amino-alcoxy pyrazoles, procede pour leur preparation, et medicaments les contenant |
| FR2513996A1 (fr) * | 1981-10-02 | 1983-04-08 | Nativelle Sa Ets | Derives du pyrazole, procede pour leur preparation et application en therapeutique |
| DE3424586A1 (de) * | 1984-07-04 | 1986-01-09 | Kali-Chemie Pharma Gmbh, 3000 Hannover | 3-aminocarbonylmethoxy-5-phenyl-pyrazol-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE4040632A1 (de) * | 1990-12-19 | 1992-06-25 | Kali Chemie Pharma Gmbh | Phenylalkylaminoalkyl-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
-
1993
- 1993-12-08 DE DE4341749A patent/DE4341749A1/de not_active Withdrawn
-
1994
- 1994-11-07 IL IL11153994A patent/IL111539A0/xx unknown
- 1994-11-08 AU AU77694/94A patent/AU7769494A/en not_active Abandoned
- 1994-11-08 NZ NZ264883A patent/NZ264883A/en unknown
- 1994-11-30 ZA ZA949537A patent/ZA949537B/xx unknown
- 1994-12-02 CZ CZ943031A patent/CZ303194A3/cs unknown
- 1994-12-02 HU HU9403458A patent/HUT68518A/hu unknown
- 1994-12-05 EP EP94119149A patent/EP0663395B1/de not_active Expired - Lifetime
- 1994-12-05 DE DE59409756T patent/DE59409756D1/de not_active Expired - Fee Related
- 1994-12-05 AT AT94119149T patent/ATE201200T1/de not_active IP Right Cessation
- 1994-12-05 ES ES94119149T patent/ES2156135T3/es not_active Expired - Lifetime
- 1994-12-06 SK SK1506-94A patent/SK150694A3/sk unknown
- 1994-12-06 JP JP30235994A patent/JP3492433B2/ja not_active Expired - Fee Related
- 1994-12-06 CA CA002137446A patent/CA2137446A1/en not_active Abandoned
- 1994-12-07 KR KR1019940033139A patent/KR950017965A/ko not_active Application Discontinuation
- 1994-12-07 NO NO944722A patent/NO944722L/no unknown
- 1994-12-07 PL PL94306155A patent/PL306155A1/xx unknown
- 1994-12-07 FI FI945750A patent/FI945750A/fi unknown
- 1994-12-07 CN CN94119876A patent/CN1109051A/zh active Pending
- 1994-12-08 RU RU94045839/04A patent/RU94045839A/ru unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI945750A (fi) | 1995-06-09 |
| HU9403458D0 (en) | 1995-02-28 |
| AU7769494A (en) | 1995-06-15 |
| CA2137446A1 (en) | 1995-06-09 |
| JPH07196622A (ja) | 1995-08-01 |
| EP0663395B1 (de) | 2001-05-16 |
| DE59409756D1 (de) | 2001-06-21 |
| ATE201200T1 (de) | 2001-06-15 |
| PL306155A1 (en) | 1995-06-12 |
| CN1109051A (zh) | 1995-09-27 |
| IL111539A0 (en) | 1995-01-24 |
| KR950017965A (ko) | 1995-07-22 |
| RU94045839A (ru) | 1996-09-27 |
| DE4341749A1 (de) | 1995-06-14 |
| EP0663395A1 (de) | 1995-07-19 |
| JP3492433B2 (ja) | 2004-02-03 |
| NO944722L (no) | 1995-06-09 |
| FI945750A0 (fi) | 1994-12-07 |
| CZ303194A3 (en) | 1995-08-16 |
| NZ264883A (en) | 1995-12-21 |
| NO944722D0 (no) | 1994-12-07 |
| ZA949537B (en) | 1995-08-11 |
| HUT68518A (en) | 1995-06-28 |
| ES2156135T3 (es) | 2001-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0474561B1 (fr) | Arylalkylamines, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
| AU680037B2 (en) | Piperazine derivatives as alpha1a-adrenergic receptor antagonists | |
| FR2676054A1 (fr) | Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| US8273733B2 (en) | Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics | |
| US7674821B2 (en) | N-[(4,5-diphenyl-3-alkyl-2-thienyl)methyl]amine [amide, sulfonamide, carbamate and urea) derivatives as cannabinoid CB1 receptor antagonists | |
| US5225585A (en) | Production of fluoxetine and new intermediates | |
| JP2722250B2 (ja) | 新規なジアミン化合物及びこれを含有する脳機能障害改善剤 | |
| NO327535B1 (no) | Produkter av amidinderivater samt anvendelse derav og medikament og farmasoytisk preparat | |
| PL210131B1 (pl) | Pochodne sulfonoamidowe, sposób ich wytwarzania, środek farmaceutyczny i zastosowanie tych pochodnych | |
| HU186584B (en) | Process for producing new benzodiazepine derivatives | |
| EP0074768A2 (en) | Alkanoylanilides | |
| SK150694A3 (en) | 1-(phenylalkylaminoalkoxy)-5-phenylpyrazole compounds, as their method and intermediates for their production | |
| HU211517A9 (en) | 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them | |
| JPS6047255B2 (ja) | ２−アミノ−５−スルフアモイル−安息香酸アミドの製法 | |
| US5547967A (en) | (Phenylalkylaminoalkyloxy)-heteroaryl-compounds, processes and intermediates for their production and pharmaceutical compositions containing them | |
| EP0333938B1 (en) | 2-hydroxy-3-aryloxy-propylamine derivatives having cardiovascular activity | |
| HU202506B (en) | Process for producing benzoxazolone derivatives | |
| HU192090B (en) | Process for preparing new tetrazolyl derivatives and pharmaceutical compositions containing such compounds | |
| EP0133259A2 (en) | Aminoalkyl-substituted benzene derivatives, process for production thereof, and pharmaceutical composition thereof | |
| KR810001889B1 (ko) | 페닐에틸아민류의 제조방법 | |
| KR810001887B1 (ko) | 페닐에틸아민류의 제조방법 | |
| KR810001891B1 (ko) | 페닐 에틸 아민류의 제조방법 | |
| EP0078546A1 (en) | Novel imidazolecarboxamide derivatives | |
| KR810001892B1 (ko) | 페닐 에틸 아민류의 제조방법 | |
| FR2678267A1 (fr) | Arylalkylamines, procede pour leur preparation et compositions pharmaceutiques les contenant. |